Procter & Gamble Gestion
Gestion contrôle des critères 4/4
Le PDG Procter & Gamble est Shailesh Jejurikar, nommé en Jan2026, a un mandat de moins d'un an. La rémunération annuelle totale est $ 9.59M, composée du salaire de 12.1% et des bonus 87.9%, y compris les actions et options de la société. détient directement 0.004% des actions de la société, d'une valeur de $ 12.68M. La durée moyenne de mandat de l'équipe de direction et du conseil d'administration est respectivement 3.6 ans et 4.7 ans.
Informations clés
Shailesh Jejurikar
Directeur général
US$9.6m
Rémunération totale
| Pourcentage du salaire du PDG | 12.12% |
| Durée du mandat du directeur général | less than a year |
| Propriété du PDG | 0.004% |
| Durée moyenne d'occupation des postes de direction | 3.6yrs |
| Durée moyenne du mandat des membres du conseil d'administration | 4.7yrs |
Mises à jour récentes de la gestion
Recent updates
Mise à jour du récit • May 04
PG: Brand Partnerships And Product Pipeline Will Support Future Shareholder Returns
Analysts have trimmed their Procter & Gamble price target slightly to about $164.09, reflecting modestly lower assumptions for revenue and profit margins while applying a slightly higher future P/E outlook. What's in the News P&G maintained fiscal 2026 guidance, with all-in sales growth expected in a 1% to 5% range and diluted EPS growth targeted in a 1% to 6% range versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Seeking Alpha • Apr 25
Procter & Gamble: Fundamentals Are Solid, But The Price Is Too High - Downgrading From Buy To Hold
Summary Procter & Gamble is downgraded from buy to hold due to macroeconomic headwinds and valuation concerns. PG continues to deliver robust, broad-based organic sales growth of 3%, with strength in both volume and pricing. The company’s growth is well-diversified across regions and product categories, underscoring resilience despite poor consumer confidence. Current valuation does not adequately reflect heightened macro uncertainty, making a hold rating more justifiable at this time. Read the full article on Seeking Alpha
Nouveau récit • Apr 24
Procter & Gamble (PG): The Beauty-Driven Beat and the Resilience of Staples
Procter & Gamble (PG) , the global vanguard of consumer staples, enters the afternoon of Friday, April 24, 2026 , as a beacon of stability following its Q3 Fiscal 2026 earnings report released this morning. The Cincinnati-based giant delivered a solid "beat-and-raise" performance, reporting Core EPS of $1.59 , surpassing the Wall Street consensus of $1.56.Mise à jour du récit • Apr 20
PG: Buybacks And Brand Partnerships Will Support Future Shareholder Returns
Analysts have slightly reduced their price target on Procter & Gamble to $164.18 from $166.95, reflecting modestly lower assumptions for revenue growth, profit margins, fair value, and future P/E multiples. What's in the News P&G revised its fiscal 2026 diluted EPS growth outlook to a range of 1% to 6%, from a prior range of 3% to 9%, citing higher non core restructuring charges, while keeping all in sales growth guidance at 1% to 5% versus the prior year (Corporate guidance).Mise à jour du récit • Apr 05
PG: Share Repurchases And Premium Portfolio Refresh Will Support Future Returns
Analysts have slightly reduced their average price target for Procter & Gamble to about $167 from $168, reflecting updated views on margins and forward P/E assumptions while keeping core growth expectations largely intact. What's in the News OLAY shared new skin aging research at the 2026 American Academy of Dermatology meeting, focusing on cell adhesion as a key factor in visible aging and applying these findings to peptide based products across the Regenerist line and the new Regenerist Treatments collection (Product announcement).Mise à jour du récit • Mar 22
PG: Product Refresh And Buybacks Will Support Future Earnings Resilience
Analysts kept their Procter & Gamble price target steady at $168. This reflects largely unchanged views on fair value, discount rate, revenue growth, profit margin, and future P/E assumptions.Mise à jour du récit • Mar 08
PG: Brand Refresh And Buybacks Will Support Stable Earnings Outlook
Analysts have maintained their Procter & Gamble price target at $168, reflecting unchanged assumptions around revenue growth, profit margins, and future P/E. This suggests that recent research has not materially shifted their valuation view.Mise à jour du récit • Feb 21
PG: Brand Activity And Buybacks Will Support Stable Margins And Outlook
Analysts have nudged their price target for Procter & Gamble higher to $168.00 from $167.45, reflecting updated assumptions for revenue growth, slightly higher profit margins and a marginally lower future P/E multiple. What's in the News Tide launched Tide evo, a 100% concentrated, waterless laundry tile with six cleaning layers and no plastic bottles, positioned to address demand for products that align with hygiene and sustainability preferences in the U.S. (Product related announcement) Head & Shoulders introduced BARE Itchy Scalp Relief Serum, aimed at providing clinically tested dandruff protection and itch relief between washes, with a nationwide U.S. launch planned for January 2026.Mise à jour du récit • Feb 07
PG: Premium Brand Extensions And Stable Margins Will Support A Balanced Outlook
Analysts have nudged their price target on Procter & Gamble slightly higher to US$167.45 from about US$165.32, reflecting updated assumptions for fair value, discount rate, revenue growth, profit margins and future P/E. What's in the News Old Spice launched the Spice Alchemist collection, a premium cologne-infused deodorant, body wash and body mist line positioned against high end fragrances.
Mise à jour du récit • Jan 25
Q2 2026 Update
Update narrative with most recent financial statements.Mise à jour du récit • Jan 23
PG: Share Repurchases And Margin Pressures Will Shape A Balanced Outlook
Analysts have trimmed their price target on Procter & Gamble to US$165 from US$168, citing updated views on revenue growth, profit margins, and the future P/E multiple. What's in the News P&G updated its fiscal 2026 guidance, keeping all in sales growth for the year in a range of 1% to 5% versus the prior year, while lowering the diluted EPS growth outlook to 1% to 6% from the previous 3% to 9% range, citing higher non core restructuring charges versus fiscal 2025 diluted EPS of US$6.51 (Corporate guidance).Mise à jour du récit • Jan 07
PG: Share Repurchase Will Support Future Upside With Stable Long Term Outlook
Narrative Update on Procter & Gamble The analyst price target for Procter & Gamble has shifted slightly, with updated assumptions around fair value at about $168.13, discount rate at 6.96%, revenue growth at roughly 3.12%, profit margin near 19.58%, and future P/E around 26.08x, as analysts fine tune their models on the company. What's in the News Pantene is partnering again with social media creator Alix Earle to promote the Abundant & Strong 3-Step System, including limited-edition Alix x Pantene Kits that bundle the three products with a free cosmetics bag and hairbrush for a limited time (product-related announcement).Mise à jour du récit • Dec 16
PG: Share Repurchase Will Support Future Upside Amid Stable Long Term Outlook
Analysts have nudged their price target for Procter & Gamble slightly lower to approximately $168.50 from about $169.05, reflecting modestly softer long term revenue growth expectations that are only partially offset by a marginally improved profit margin outlook and a slightly lower assumed future valuation multiple. What's in the News Pantene launched the Abundant & Strong Collection, a three step system clinically shown to reduce hair loss by up to 85% by targeting scalp oxidative stress with a Pro Vitamin Complex plus Niacinamide technology.Mise à jour du récit • Dec 02
PG: Share Repurchase And New Collections Will Drive Continued Momentum
Procter & Gamble's analyst price target remains unchanged at $169.05 as analysts maintain stable estimates based on consistent fair value metrics and minimal adjustments to key financial assumptions. What's in the News Pantene launches the Abundant & Strong Collection, a new three-step system designed to reduce hair loss by up to 85% and promote stronger, denser hair using antioxidant technology.Mise à jour du récit • Nov 18
PG: Share Buybacks And New Guidance Will Support Steady Uptrend
Analysts have maintained Procter & Gamble's price target at $169.05 per share. There have been only minor adjustments to underlying valuation factors, supporting a steady outlook for the company.Mise à jour du récit • Nov 03
PG: Share Buyback And Product Rollout Will Drive Long-Term Upside
Analysts have slightly raised their price target for Procter & Gamble to $169.05 from $168.64. They cite incremental improvements in revenue growth forecasts even as profit margin projections moderate.Mise à jour du récit • Oct 20
Rising Consumer Confidence And Product Investment Will Expand US Markets
Analysts have slightly lowered their price target for Procter & Gamble from $170.95 to $168.64 per share. They cite modest reductions in projected revenue growth, which are partially offset by improved profit margins and valuation multiples.Article d’analyse • Aug 06
The Procter & Gamble Company (NYSE:PG) Just Reported Full-Year Earnings: Have Analysts Changed Their Mind On The Stock?
NYSE:PG 1 Year Share Price vs Fair Value Explore Procter & Gamble's Fair Values from the Community and select yours The...Nouveau récit • Jul 21
Procter & Gamble: A Dividend Giant Facing Slowing Growth
United States: 48.21%1-Year Revenue Growth = 4.65%Article d’analyse • Jun 27
The Procter & Gamble Company (NYSE:PG) Shares Could Be 21% Below Their Intrinsic Value Estimate
Key Insights The projected fair value for Procter & Gamble is US$200 based on 2 Stage Free Cash Flow to Equity Procter...Seeking Alpha • Apr 22
Procter & Gamble: Hold This Stodgy Stalwart
Summary Procter & Gamble is a global consumer product leader, with a strong market presence and consistent, albeit slow, growth in revenue and earnings. Despite being overvalued, PG's profitability remains robust, with reliable cash flow and a solid gross profit margin above industry medians. PG's valuation poses a risk, with a high PEG ratio indicating slow growth, yet it maintains a decent dividend yield and outpaces peers in performance. PG is a safe investment but lacks excitement; it's a hold due to its steady but lethargic growth and overvaluation concerns. Read the full article on Seeking AlphaAnalyse de la rémunération des PDG
| Date | Rémunération totale | Salaire | Bénéfices de l'entreprise |
|---|---|---|---|
| Mar 31 2026 | n/a | n/a | US$16b |
| Dec 31 2025 | n/a | n/a | US$16b |
| Sep 30 2025 | n/a | n/a | US$16b |
| Jun 30 2025 | US$10m | US$1m | US$16b |
| Mar 31 2025 | n/a | n/a | US$15b |
| Dec 31 2024 | n/a | n/a | US$15b |
| Sep 30 2024 | n/a | n/a | US$14b |
| Jun 30 2024 | US$10m | US$1m | US$15b |
| Mar 31 2024 | n/a | n/a | US$15b |
| Dec 31 2023 | n/a | n/a | US$14b |
| Sep 30 2023 | n/a | n/a | US$15b |
| Jun 30 2023 | US$8m | US$1m | US$14b |
| Mar 31 2023 | n/a | n/a | US$14b |
| Dec 31 2022 | n/a | n/a | US$14b |
| Sep 30 2022 | n/a | n/a | US$14b |
| Jun 30 2022 | US$7m | US$953k | US$14b |
| Mar 31 2022 | n/a | n/a | US$14b |
| Dec 31 2021 | n/a | n/a | US$14b |
| Sep 30 2021 | n/a | n/a | US$14b |
| Jun 30 2021 | US$6m | US$798k | US$14b |
Rémunération vs marché: La rémunération totale de Shailesh ($USD 9.59M ) est inférieure à la moyenne des entreprises de taille similaire sur le marché US ($USD 14.79M ).
Rémunération et revenus: La rémunération de Shailesh a été cohérente avec les performances de l'entreprise au cours de l'année écoulée.
PDG
Shailesh Jejurikar (57 yo)
less than a year
Titularisation
US$9,591,687
Compensation
Mr. Shailesh G. Jejurikar was Independent Director at Otis Worldwide Corporation (also known as Otis Elevator Company, Inc) since April 03, 2020 until September 9, 2025. He serves as CEO & President at The...
Équipe de direction
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 54.9m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.7m | |
| Chief Financial Officer | 5.2yrs | US$8.52m | 0.0026% $ 8.7m | |
| Chief Executive Officer of Health Care | 8.3yrs | US$6.04m | 0.0033% $ 11.2m | |
| Chief Executive Officer of Fabric and Home Care and P&G Ventures | 1.3yrs | US$7.18m | 0.0022% $ 7.3m | |
| Senior VP & Chief Accounting Officer | 3.8yrs | pas de données | 0.00018% $ 605.4k | |
| Chief Information Officer | 1.8yrs | pas de données | pas de données | |
| Senior Vice President of Investor Relations | no data | pas de données | pas de données | |
| Chief Legal Officer & Secretary | 4.3yrs | pas de données | 0.0016% $ 5.3m | |
| Chief Communications Officer | 6.2yrs | pas de données | pas de données | |
| President of North America & Chief Sales Officer | no data | pas de données | pas de données | |
| Chief Human Resources Officer | 3.3yrs | US$7.48m | 0.00077% $ 2.6m |
3.6yrs
Durée moyenne de l'emploi
53.5yo
Âge moyen
Gestion expérimentée: L'équipe de direction de PG est considérée comme expérimentée (ancienneté moyenne 3.6 ans).
Membres du conseil d'administration
| Nom | Position | Titularisation | Compensation | Propriété |
|---|---|---|---|---|
| Executive Chairman | 4.8yrs | US$21.91m | 0.016% $ 54.9m | |
| CEO, President & Director | less than a year | US$9.59m | 0.0038% $ 12.7m | |
| Independent Director | 6.6yrs | US$370.00k | pas de données | |
| Independent Director | 5.8yrs | US$340.00k | pas de données | |
| Lead Independent Director | 8.2yrs | US$410.00k | 0.00054% $ 1.8m | |
| Independent Director | 3.6yrs | US$340.00k | pas de données | |
| Independent Director | 3.1yrs | US$340.00k | pas de données | |
| Independent Director | 2.6yrs | US$340.00k | pas de données | |
| Independent Director | 5.3yrs | US$340.00k | pas de données | |
| Independent Director | 8.9yrs | US$360.00k | pas de données | |
| Independent Director | 4.6yrs | US$340.00k | pas de données | |
| Independent Director | 3.1yrs | US$340.00k | pas de données |
4.7yrs
Durée moyenne de l'emploi
60yo
Âge moyen
Conseil d'administration expérimenté: Les membres du conseil d'administration de PG sont considérés comme expérimentés (ancienneté moyenne 4.7 ans).
Analyse de l'entreprise et données financières
| Données | Dernière mise à jour (heure UTC) |
|---|---|
| Analyse de l'entreprise | 2026/05/25 22:26 |
| Cours de l'action en fin de journée | 2026/05/22 00:00 |
| Les revenus | 2026/03/31 |
| Revenus annuels | 2025/06/30 |
Sources de données
Les données utilisées dans notre analyse de l'entreprise proviennent de S&P Global Market Intelligence LLC. Les données suivantes sont utilisées dans notre modèle d'analyse pour générer ce rapport. Les données sont normalisées, ce qui peut entraîner un délai avant que la source ne soit disponible.
| Paquet | Données | Cadre temporel | Exemple de source américaine * |
|---|---|---|---|
| Finances de l'entreprise | 10 ans |
| |
| Estimations consensuelles des analystes | +3 ans |
|
|
| Prix du marché | 30 ans |
| |
| Propriété | 10 ans |
| |
| Gestion | 10 ans |
| |
| Principaux développements | 10 ans |
|
* Exemple pour les titres américains ; pour les titres non américains, des formulaires réglementaires et des sources équivalentes sont utilisés.
Sauf indication contraire, toutes les données financières sont basées sur une période annuelle mais mises à jour trimestriellement. C'est ce qu'on appelle les données des douze derniers mois (TTM) ou des douze derniers mois (LTM). En savoir plus.
Modèle d'analyse et flocon de neige
Les détails du modèle d’analyse utilisé pour générer ce rapport sont disponibles sur notre page Github; nous proposons également des guides expliquant comment utiliser nos rapports et des tutoriels sur Youtube.
Découvrez l'équipe de classe mondiale qui a conçu et construit le modèle d'analyse Simply Wall St.
Indicateurs de l'industrie et du secteur
Nos indicateurs de secteur et de section sont calculés toutes les 6 heures par Simply Wall St. Les détails de notre processus sont disponibles sur Github.
Sources des analystes
The Procter & Gamble Company est couverte par 43 analystes. 21 de ces analystes ont soumis les estimations de revenus ou de bénéfices utilisées comme données d'entrée dans notre rapport. Les soumissions des analystes sont mises à jour tout au long de la journée.
| Analyste | Institution |
|---|---|
| Christopher Graja | Argus Research Company |
| Lauren Lieberman | Barclays |
| Lauren Lieberman | Barclays |